These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1005168)

  • 1. [Lupus nephritis: clinico-immunological correlations based on studies of the complement system, fibrinogen (fibrin) degradation products and PHA-induced lymphocyte transformation].
    Szewczyk Z; Klinger M; Górecka Z; Ratajczak T; Melcer H
    Pol Arch Med Wewn; 1976 Nov; 56(5):419-31. PubMed ID: 1005168
    [No Abstract]   [Full Text] [Related]  

  • 2. The significance of C3 and C4 complement levels in lupus nephritis.
    Levo Y; Pick AI
    Int Urol Nephrol; 1974; 6(3-4):233-8. PubMed ID: 4549215
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinico-immunological evaluation of the activity of total complement of the blood serum of patients with systemic lupus erythematosus].
    Zhuravlev GI; Rodshtein OA
    Ter Arkh; 1972 Nov; 44(11):29-33. PubMed ID: 4125143
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrin degradation products in renal diseases.
    Kuroyanagi T; Kura K
    Tohoku J Exp Med; 1976 Jul; 119(3):237-44. PubMed ID: 785695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topics in clinical medicine. Complement levels in disease.
    Townes AS
    Johns Hopkins Med J; 1967 May; 120(5):337-43. PubMed ID: 6024563
    [No Abstract]   [Full Text] [Related]  

  • 6. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood lymphocyte response to phytomitogens in systemic lupus erythematosus.
    Foad B; Adams LE; Litwin A; Hess EV
    Ann Rheum Dis; 1975 Oct; 35(5):407-14. PubMed ID: 1234408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The measurement of complement as an aid in diagnosis: 1. Nephritis and collagen disease.
    McKay EJ; Haines DJ
    N Z Med J; 1978 May; 87(611):315-8. PubMed ID: 276704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus nephritis: immunofluorescence study of 54 cases.
    Morel-Maroger L; Méry JP; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1183-6. PubMed ID: 4610502
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of complement in human nephritis.
    Lambert PH; Perrin LH; Mahieu P; Nydegger UE; Miescher PA
    Adv Nephrol Necker Hosp; 1974; 4():79-90. PubMed ID: 4220001
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrin fibrinogen degradation products in the blood in systemic lupus erythematosus and other major collagen diseases].
    Wysocka K; Kiczak J
    Reumatologia; 1982; 20(1-2):15-21. PubMed ID: 7163659
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of circulating immune complexes in lupus nephritis by solid phase C1q and conglutinin binding assays.
    Yoshida H; Muso E; Inoue S; Furukawa F; Sekita K; Kawai C; Hamashima Y
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):293-300. PubMed ID: 6611433
    [No Abstract]   [Full Text] [Related]  

  • 13. Split products of fibrin in human renal disease.
    Stiehm ER; Trygstad CW
    Am J Med; 1969 May; 46(5):774-86. PubMed ID: 4182522
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological analysis of minimal change nephrotic syndrome and lupus nephritis: sensitivity of suppressor cells to indomethacin.
    Osaki K
    Nihon Jinzo Gakkai Shi; 1986 Mar; 28(3):255-62. PubMed ID: 2941607
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-10-globulin and complement in nephritis. Serological and immunohistological studies in acute, chronic, membranous and lupus glomerulonephritis.
    Humair LM
    Helv Med Acta; 1968 Nov; 34(4):279-96. PubMed ID: 4178684
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of serum complement in the hypocomplementaemic nephritides.
    Williams DG; Peters DK; Fallows J; Petrie A; Kourilsky O; Morel-Maroger L; Cameron JS
    Clin Exp Immunol; 1974 Nov; 18(3):391-405. PubMed ID: 4219908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation.
    Hunsicker LG; Ruddy S; Carpenter CB; Schur PH; Merrill JP; Müller-Eberhard HJ; Austen KF
    N Engl J Med; 1972 Oct; 287(17):835-40. PubMed ID: 4627271
    [No Abstract]   [Full Text] [Related]  

  • 19. Reactivities to horse anti-lymphocyte globulin. II. Serum sickness nephritis with complement alterations in man.
    Gewurz H; Pickering RJ; Moberg A; Simmons RL; Good RA; Najarian JS
    Int Arch Allergy Appl Immunol; 1970; 39(2-3):210-20. PubMed ID: 4990556
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic factors and clinical activity in systemic lupus erythematosus.
    Schur PH; Sandson J
    N Engl J Med; 1968 Mar; 278(10):533-8. PubMed ID: 4866347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.